Siemens Healthineers: Q2 results below expectations
(CercleFinance.com) - German medical device manufacturer Siemens Healthineers reported lower-than-expected quarterly results on Wednesday, and lowered some of its forecasts for 2024.
Its adjusted Ebit rose by 9% to E825m in Q2, but fell short of the E856m consensus provided by the company itself.
Sales amounted to E5.4bn in the quarter, up 4%, but again fell short of the E5.5bn consensus.
The Group maintains its outlook for FY LFL sales growth of 4.5% to 6.5%.
However, Siemens Healthineers has lowered its growth outlook for its Imaging Division to 4.5%-5.5%, compared with 6%-8% previously.
On the Frankfurt Stock Exchange, Siemens Healthineers shares slumped 7% on Wednesday morning following this warning, posting the biggest drop on the pan-European STOXX Europe 600 index.
Not only did the quarter turn out to be worse than expected, but the most important division (Imaging) performed particularly disappointingly, UBS analysts lamented.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Its adjusted Ebit rose by 9% to E825m in Q2, but fell short of the E856m consensus provided by the company itself.
Sales amounted to E5.4bn in the quarter, up 4%, but again fell short of the E5.5bn consensus.
The Group maintains its outlook for FY LFL sales growth of 4.5% to 6.5%.
However, Siemens Healthineers has lowered its growth outlook for its Imaging Division to 4.5%-5.5%, compared with 6%-8% previously.
On the Frankfurt Stock Exchange, Siemens Healthineers shares slumped 7% on Wednesday morning following this warning, posting the biggest drop on the pan-European STOXX Europe 600 index.
Not only did the quarter turn out to be worse than expected, but the most important division (Imaging) performed particularly disappointingly, UBS analysts lamented.
Copyright (c) 2024 CercleFinance.com. All rights reserved.